FDA Enforcement Tracker

STAT News: 35 of 36 BPC-157 studies are animal-only from single lab with undisclosed conflicts

Alabama obtains TRO against GLP-1 distributors — first state-level injunctive relief

FDA issues 50+ warning letters to GLP-1 compounders; DOJ involvement confirmed

FDA raids Amino Asylum warehouse; website goes offline, operations cease

FDA declares semaglutide shortage resolved — compounding exception ends

FDA eliminates Category 2/3 system; prohibited substances remain prohibited

Chinese peptide imports to US double to $328M; online peptide advertising up 678% since 2022

PCAC votes against allowing compounding of ipamorelin, MK-677, CJC-1295, AOD-9604

FDA moves BPC-157, TB-500, and 15 other peptides to Category 2 — compounding prohibited